Information for NAO Suspension for Surgery Interventions
Information for oral anticoagulants (NAO) suspension for surgery interventions.
Source: 2018 EHRA Practical Guide on NOACs in AF – J. Steffel et al. (European Heart Journal (2018) 39, 1330–1393) – doi:10.1093/eurheartj/ehy136
Indications for the suspension of NAO for surgery:
The surgeon / anesthesiologist / dentist must:
Have blood chemistry tests with kidney function (creatinine) checked and calculate eGFR according to Cockcroft – Gault (maximum 30 days before surgery).
Estimate the risk of bleeding of the intervention that must be performed.
Stop the drug following the indications given in the table on page 1 and indicate the resumption of therapy on the basis of the post-operative course. NB: for interventions with minimum and low risk of bleeding, the bridge with heparins is NEVER indicated (not even with low molecular weight).
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.